PFEPfizer Inc.
Pfizer Inc. (PFE) is a NYSE-listed equity covered by Valdrans. Last close $28.280, +1.65% on the day; +1.73% over 1 week, +2.02% over 4 weeks, +5.05% over 6 months (prices as of 9 Oct 2026). Valdrans Insider Activity Signal: Positive — 3 buys vs 1 sell disclosed in the last 90 days.
- Last close (9 Oct 2026)
- $28.280
- Today
- +1.65%
- 1 week
- +1.73%
- 4 weeks
- +2.02%
- 6 months
- +5.05%
- Insider signal
- Positive
- Latest coverage
- PFE Q3 2026 update — filings and holdings
$28.280USD
+1.65% today
1 week+1.73%
4 weeks+2.02%
6 months+5.05%
Coverage of PFE(16)
PFE Q3 2026 update — filings and holdings
PFE Q3 2026 update — filings and holdings
PFE Q3 2026 update — filings and holdings
PFE Q2 2026: filings, holdings, and macro context
PFE Q2 2026: filings, holdings, and macro context
PFE Q2 2026 update — filings and holdings
PFE Q2 2026 update — filings and holdings
PFE Q2 2026 update — filings and holdings
PFE Q2 2026 update — filings and holdings
PFE Q2 2026 update — filings and holdings
PFE Q2 2026 update — filings and holdings
PFE Q2 2026 update — filings and holdings
GSK's Bexsero chosen for UK MenB rollout to 1 million students
The NHS will offer GSK's two-dose Bexsero vaccine to around one million Year 13 pupils and under-25s starting university this autumn, following a meningitis B outbreak in Kent.